Overview

A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections

Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the clinical efficacy of a traditional Chinese medicine formula granule (Feireqing Granules) in the treatment of severe pneumonia caused by multidrug-resistant Gram-negative bacterial infections (MDR-GNB severe pneumonia), to establish a therapeutic regimen, and to generate high-quality clinical evidence.
Phase:
NA
Details
Lead Sponsor:
Henan University of Traditional Chinese Medicine
Collaborators:
Henan Provincial Hospital of TCM
Henan Provincial People's Hospital
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
The First Affiliated Hospital of Zhengzhou University
Third Affiliated Hospital of Henan University of Traditional Chinese Medicine